Professor Kwee Yong was educated at Oxford University and University College London (UCL). She was awarded a PhD from London University in 1993 her work on growth factors. Professor Yong returned to UCL as Senior Lecturer and Honorary Consultant in 1999, since when she has been clinical and academic lead in multiple myeloma at University College Hospital. Professor Yong is a member of the UK Myeloma Research Alliance and is chief investigator on several National Cancer Research Network trials involving new treatment regimens and paradigm changing strategies in multiple myeloma. She is a member of the National Cancer Research Institute Haematological Oncology Clinical Studies Group, the Cancer Research UK clinical careers committee and the Myeloma UK Clinical Trials network established in 2009 to run early phase studies in the UK. She has contributed to the recent revision of the UKMF/Nordic myeloma guidelines (British Journal of Haematology, 2011). She is chair of the executive board of the UK Myeloma Forum, and acts as clinical expert for NICE technology appraisals. She is a regular speaker at national and international meetings.
Professor Yong also runs a laboratory programme working on myeloma biology and immunology, and the mechanisms of bone disease. This programme has received funding from Cancer Research UK, Kay Kendall Leukemia Fund, the Wellcome Trust and Bloodwise. She has published over 100 original papers in peer-reviewed journals, and is a reviewer for international journals and grant-awarding bodies. Professor Yong is the NIHR training lead for Academic Clinical Fellows and Clinical Lecturers at UCL.